The B2B Podcast Index
Index
All categories
MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
MethodologySubmit
Best of:MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
An independent project byFame
SearchBest episodesGuestsInsightsMethodologySubmit a podcast
#902Value Health Voices73.0 / 100Get badge
← The Index
Value Health Voices artwork
FinanceNEW this period

Value Health Voices

Hosted by Dr. Amar Rewari and Dr. Anthony Paravati

We discuss the most impactful health policy and healthcare finances developments shaping the US Healthcare system now and in the future. We also discuss personal development for physician executives. Co-hosts Dr Anthony Paravati and Dr Amar Rewari.

36 episodes · publishes fortnightly · latest 2026-07-03 · ~46 min/episode

Rank

#902

Substance

73.0

/ 100

Breakdown

Scored 2026-07
Updated monthly

Finance rank

#132 of 548

Best B2B Finance Podcasts →

Across the index

#902 of 6183

Substance

Top 15%

outscores 85% of the index

Why it scores where it does

Value Health Voices ranks #902 on The B2B Podcast Index with a substance score of 73.0 out of 100, scored across 1 recent episode. It scores highest on guest caliber and specificity & evidence. Dr. Husri is a legitimate operator-practitioner: a radiation oncologist who co-founded and has run MedNet for 12 years, received NSF and NCI grants, went through Y Combinator, and was invited to the ASTRO Presidential Symposium. She speaks from genuine build experience, not punditry, though the company remains relatively small and niche.

The five-dimension breakdown

Averaged across 1 recently scored episode, with cited evidence.

Insight Density

14.0 / 20

There are a handful of genuinely useful data points - only 7% of NCCN recommendations derive from Phase 3 RCTs, MedNet AI surfaces community Q&A 80% of the time, LLMs answer complex oncology questions accurately ~30% of the time - but these are spaced far apart across 56 minutes of personal anecdotes, restatements, and affirmations. The insight-per-minute rate is low.

“only like, I think it's like 7% of the recommendations are come from phase three randomized trials”

“80% of them actually result in Q and A from MedNet. So 80% of the time your question is pulling from the experience and the knowledge of the community”

Originality

14.0 / 20

The comparison of pediatric vs. adult oncologist default mindset on clinical trials is a genuinely non-obvious insight, and hard-coding 'the answer is not known' into their AI is a meaningful design distinction. However, the broader framing - LLMs hallucinate on complex cases, medicine is art and science, AI should assist not replace - is thoroughly recycled discourse.

“the first question a pediatric oncologist asks themselves when they see a new patient is what trial do I have for this patient? That's like maybe first question adult oncologist asks is what's first line, what's second line, what's third line?”

“we actually designed it to say like that the answer is not known like not to extrapolate”

Guest Caliber

18.0 / 20

Dr. Husri is a legitimate operator-practitioner: a radiation oncologist who co-founded and has run MedNet for 12 years, received NSF and NCI grants, went through Y Combinator, and was invited to the ASTRO Presidential Symposium. She speaks from genuine build experience, not punditry, though the company remains relatively small and niche.

“we went through Y Combinator and had funding from, from them”

“we have a team of. Right now we're six physicians at MedNet. So it's. Everything that we develop is product engineering, medical”

Specificity & Evidence

15.0 / 20

Several concrete metrics are cited - 7% NCCN Phase 3 evidence rate, 80% community Q&A pull rate, ~30% LLM accuracy on complex oncology queries, 73-day knowledge doubling time - but sourcing is loose throughout, the 30% figure is introduced by the host without a named study, and many claims about AI limitations and physician behavior are asserted without grounding.

“large language models performing in terms of completely accurate responses for difficult oncologic questions. Something like 30% or less”

“80% of them actually result in in Q and A from MedNet”

Conversational Craft

12.0 / 20

The hosts did real preparation - they surface the ASTRO 2022 predictions, cite a specific study, and use a structured three-prediction framework - but the personal friendship dynamic produces consistent softballing, the hosts frequently complete the guest's sentences or answer questions themselves, and there is no meaningful pushback on any claim throughout the episode.

“Were you worried at the time or even now, I guess that with all these companies doing these investments in LLMs in this space, like you said, they're kind of going almost head to head a little bit against what you are providing”

“That's. It's a great example”

Standout episodes

  • The Three Words AI Won't Say: Inside Mednet's Bet on Honest Medicine

    2026-05-28

    73

Rank over time

First period on the Index - history builds from here.

Episodes

1 scored on substance · 36 tracked in total.

  • The Three Words AI Won't Say: Inside Mednet's Bet on Honest Medicine

    2026-05-28 · 56 min

    73 / 100

Frequently asked

What is Value Health Voices's substance score?
Value Health Voices scores 73.0 out of 100 for substance and ranks #902 on The B2B Podcast Index. That puts it ahead of 85% of the B2B podcasts we rank and #132 of 548 in Finance. The score reflects insight density, originality, guest caliber, specificity and conversational craft across recent episodes - not downloads.
Is Value Health Voices worth listening to?
Yes - Value Health Voices outscores 85% of the B2B finance podcasts and shows we rank on substance, so a finance operator is likely to come away with something useful.
Who hosts Value Health Voices?
Value Health Voices is hosted by Dr. Amar Rewari and Dr. Anthony Paravati.
How often does Value Health Voices publish?
Value Health Voices publishes fortnightly, has 36 episodes, released its most recent episode on 2026-07-03.
Which Value Health Voices episode should I start with?
Our highest-scoring recent episode is "The Three Words AI Won't Say: Inside Mednet's Bet on Honest Medicine" (73/100) - a good place to start.

Show off your #132 rank in Finance

Add this badge to your site - it links back here and updates automatically as you rank.

Ranked #132 on The B2B Podcast Index
Embed code
<a href="https://index.fame.so/show/value-health-voices" target="_blank" rel="noopener">
  <img src="https://index.fame.so/badge/value-health-voices/badge.svg" alt="Ranked #132 on The B2B Podcast Index" width="360" height="136" />
</a>
Markdown & other formats →

Track Value Health Voices's rank

Get an email whenever this show moves up or down the Index. Monthly at most, no spam.

Listen / subscribe:WebsiteRSS

Frequently discusses

Companies, products and tools that come up most across this show's episodes.

MedNetYale School of MedicineNational Science FoundationNational Comprehensive Cancer NetworkChatGPTStack OverflowASTROSWOGPubMedUp to Date

Guests who've appeared

Dr. Nadine Husri

Topics this show covers

The themes that come up most across this show's episodes.

Large language modelsStack OverflowMedNetNCCN guidelinesclinical trials matchingSWOGknowledge sharing platformsmachine learning in oncologytracheal cancer treatmentmedical knowledge doubling time

More Finance podcasts

See all →
  • Oil Ground Up

    Oil Ground Up

    96.0
  • Private Capital Call

    Private Capital Call

    90.0
  • Value Hive Podcast

    Brandon Beylo

    89.0
  • SRI360

    Scott Arnell

    88.2
  • Financial Advisor Success

    Michael Kitces

    88.0
  • A Sustainable Future

    Man Group

    87.0

Similar shows

Podcasts that dig into the same topics.

  • The Digital Leader Show

    Institute for RPA & AI

    76.0
  • Software Sessions

    Jeremy Jung

    84.0
  • The Road to Accountable AI

    Kevin Werbach

    84.0
  • SaaS Backwards

    Ken Lempit

    83.2
  • Radio Advisory

    Advisory Board

    83.2
  • B2B Marketing with Fexingo

    Fexingo

    83.0